- Conditions
- Type 2 Diabetes
- Interventions
- Continuous Glucose Monitoring (CGM), The DECIDE Self-Management Program
- Behavioral
- Lead sponsor
- Northwell Health
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026
- U.S. locations
- 1
- States / cities
- Manhasset, New York
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
The live registry is temporarily unavailable. These stored records may be incomplete or out of date. Check the official record for current status and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1009–1032
of 1,072
matching trials from the local directory fallback.
- Conditions
- Gestational Diabetes, Pregnancy Complications
- Interventions
- GDM Prevention Program
- Behavioral
- Lead sponsor
- Indiana University
- Other
- Eligibility
- 14 Years and older · Female only
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2031
- U.S. locations
- 1
- States / cities
- Indianapolis, Indiana
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- Colecalciferol 2000 IU, Placebo, Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
- Dietary Supplement · Biological
- Lead sponsor
- Diamyd Medical AB
- Industry
- Eligibility
- 12 Years to 28 Years
- Enrollment
- 321 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2026
- U.S. locations
- 13
- States / cities
- Newport Beach, California • Palo Alto, California • San Diego, California + 10 more
- Conditions
- Diabetes (DM), Diabetes (Insulin-requiring, Type 1 or Type 2), Diabetes in Adolescence, Diabetes in Children
- Interventions
- MiniMed Fit Payload adhesive components
- Device
- Lead sponsor
- Medtronic MiniMed, Inc.
- Industry
- Eligibility
- 7 Years to 17 Years
- Enrollment
- 59 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026
- U.S. locations
- 5
- States / cities
- Sacramento, California • Santa Barbara, California • Idaho Falls, Idaho + 2 more
- Conditions
- Liver Transplant, Post Transplant Diabetes, Type 2 Diabetes
- Interventions
- Libre 3+
- Device
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Overweight and Obesity, PreDiabetes, Prediabetic State
- Interventions
- Empagliflozin, Multivitamin-Placebo
- Drug
- Lead sponsor
- Oregon State University
- Other
- Eligibility
- 18 Years to 59 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2026
- U.S. locations
- 1
- States / cities
- Corvallis, Oregon
- Conditions
- Diabetes Mellitus, Type 1, Pregnancy in Diabetes
- Interventions
- Metformin
- Drug
- Lead sponsor
- Maisa N. Feghali, MD
- Other
- Eligibility
- 18 Years to 50 Years · Female only
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2026
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Diabetes, Dyslipidemia, Emergency Medicine, Hyperglycemia, Hyperlipidemia, Hypertension, Metabolic Syndrome, Obesity &Amp; Overweight
- Interventions
- Composite intervention to address MetS
- Behavioral
- Lead sponsor
- Indiana University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Indianapolis, Indiana
- Conditions
- Artificial Intelegence, Remote Patient Monitoring, T2D, T2DM, T2DM (Type 2 Diabetes Mellitus), Type 2 Diabetes, Type 2 Diabetes Mellitus (T2DM)
- Interventions
- Fitbit and AI Chatbot, Routine Care
- Behavioral · Other
- Lead sponsor
- University of Colorado, Denver
- Other
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 35 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Aurora, Colorado
- Conditions
- Healthy, Obesity, Overweight, Type 2 Diabetes
- Interventions
- LY4086940, Placebo
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 219 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2026
- U.S. locations
- 4
- States / cities
- Daytona Beach, Florida • Miami, Florida • Dallas, Texas + 1 more
- Conditions
- Type 2 Diabetes
- Interventions
- Produce Gift Card and Dietary Education, Usual Care
- Behavioral · Other
- Lead sponsor
- West Virginia University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 88 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Morgantown, West Virginia
- Conditions
- Gestational Diabetes Mellitus in Pregnancy, Neonatal Hypoglycemia, Pregestational Diabetes Mellitus
- Interventions
- Liberalized Intrapartum Glucose Target Range, Standard Intrapartum Glucose Target Range
- Other
- Lead sponsor
- University of Pittsburgh
- Other
- Eligibility
- Female only
- Enrollment
- 169 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2026
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Gestational Diabetes, Type 2 Diabetes
- Interventions
- Active Comparator, Glucose tolerance test (2 hour)
- Other · Diagnostic Test
- Lead sponsor
- University of Massachusetts, Worcester
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 116 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Worcester, Massachusetts
- Conditions
- Type 2 Diabetes
- Interventions
- Stable isotope infusion, oral glucose ingestion, intravenous arginine bolus
- Other
- Lead sponsor
- Baylor College of Medicine
- Other
- Eligibility
- 12 Years to 20 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2026
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Type 2 Diabetes
- Interventions
- Digital Navigation
- Other
- Lead sponsor
- Brigham and Women's Hospital
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 64 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2026
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Impaired Glucose Tolerance, Prediabetes
- Interventions
- CGM
- Device
- Lead sponsor
- Nemours Children's Clinic
- Other
- Eligibility
- 10 Years to 18 Years
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2026
- U.S. locations
- 1
- States / cities
- Jacksonville, Florida
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Diabetes Self-Management Education, Peer Led Diabetes Self-Management Support
- Behavioral
- Lead sponsor
- University of Michigan
- Other
- Eligibility
- 21 Years and older · Male only
- Enrollment
- 51 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2025
- U.S. locations
- 1
- States / cities
- Ann Arbor, Michigan
- Conditions
- Pediatric Obesity, Time Restricted Eating, Type 2 Diabetes
- Interventions
- Components Common to All Study Arms., Continuous Glucose Monitor, Control, Time Limited Eating
- Behavioral · Device
- Lead sponsor
- Children's Hospital Los Angeles
- Other
- Eligibility
- 12 Years to 21 Years
- Enrollment
- 87 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2026
- U.S. locations
- 1
- States / cities
- Los Angeles, California
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Medical Nutrition Therapy
- Behavioral
- Lead sponsor
- The University of Texas Medical Branch, Galveston
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 48 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2026
- U.S. locations
- 1
- States / cities
- Galveston, Texas
- Conditions
- Type 1 Diabetes
- Interventions
- Dextrose, Jell-O with Amino acids, Muscle Biopsy
- Dietary Supplement · Other · Procedure
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 18 Years to 70 Years
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026
- U.S. locations
- 1
- States / cities
- Rochester, Minnesota
- Conditions
- Cystic Fibrosis Related Diabetes
- Interventions
- Not listed
- Lead sponsor
- University of Alabama at Birmingham
- Other
- Eligibility
- 21 Years to 75 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 1
- States / cities
- Birmingham, Alabama
- Conditions
- Diabetes Mellitus, Type 1
- Interventions
- HDV-Lispro, Lispro
- Drug
- Lead sponsor
- Diasome Pharmaceuticals
- Industry
- Eligibility
- 18 Years to 79 Years
- Enrollment
- 227 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2025
- U.S. locations
- 27
- States / cities
- Huntington Beach, California • Pasadena, California • Tustin, California + 23 more
- Conditions
- Obesity, Obstructive Sleep Apnea, Overweight, Type 2 Diabetes
- Interventions
- Placebo, Retatrutide
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 1,152 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2026
- U.S. locations
- 40
- States / cities
- Anniston, Alabama • Cullman, Alabama • Little Rock, Arkansas + 36 more
- Conditions
- Diabetes, Diabetes Complications, Diabetes Mellitus, Type 2, Diabetic Kidney Disease, Diabetic Nephropathies, Hyperuricemia, Type 2 Diabetes Mellitus, Type2 Diabetes
- Interventions
- Pegloticase 8 MG/ML [Krystexxa]
- Drug
- Lead sponsor
- University of Colorado, Denver
- Other
- Eligibility
- 18 Years to 25 Years · Male only
- Enrollment
- 11 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2023
- U.S. locations
- 1
- States / cities
- Aurora, Colorado